BioXcel Therapeutics Inc. (BTAI)

AI Score

Unlock

1.83

0.19 (11.59%)

At close: Apr 11, 2025, 3:59 PM

1.76

-3.77%

After-hours: Apr 11, 2025, 05:39 PM EDT

BioXcel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Mar 31, 2017
Cash & Equivalents	29.85M	40.39M	56.27M	74.14M	65.22M	89.96M	127.55M	165.52M	193.72M	232.31M	233.45M	200.44M	232.97M	252.91M	273.06M	194.01M	213.12M	233.43M	65.5M	80.08M	32.43M	40.25M	29.96M	36.3M	42.56M	47.12M	50.35M	55.47M	887K	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	87K	87K	87K	87K	87K	87K	87K	925K	925K	925K	925K	965K	3.93M	1.75M	1.63M	633K	87K	86K	51K	51K	51K	51K	429K	51K	51K	51K	n/a	n/a	461K	n/a
Receivables	131K	3K	812K	378K	71K	735K	431K	283K	248K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	46K	n/a	115K	49K	70K	44K	n/a	n/a
Inventory	679K	1.52M	2.68M	2.44M	1.99M	2.02M	1.93M	1.95M	1.99M	1.41M	1.4M	682K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.44M	1.4M	1.64M	1.86M	2.08M	2.17M	4.64M	5.01M	3.84M	2.43M	1.69M	1.48M	956K	n/a	3.6M	2.77M	3.95M	2.71M	n/a	3.52M	n/a	1.11M	n/a	1.78M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	37.39M	47.79M	64.18M	80.92M	72.14M	98.74M	138.24M	177.27M	202.87M	241.66M	244.92M	207.56M	232.97M	256.93M	276.66M	196.78M	217.06M	236.13M	68.31M	83.6M	34.11M	41.36M	31.51M	38.08M	43.17M	47.64M	51.09M	56.32M	890K	n/a
Property-Plant & Equipment	857K	1.01M	1.17M	1.32M	1.47M	1.62M	1.77M	1.91M	2.06M	2.23M	2.39M	2.52M	2.54M	2.65M	2.82M	2.97M	2.78M	2.53M	2.1M	2.16M	2.23M	2.29M	2.34M	2.2M	327K	177K	122K	4K	4K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	944K	1.1M	1.25M	1.41M	1.56M	1.71M	1.86M	2.83M	2.98M	3.16M	3.31M	3.48M	6.47M	4.4M	4.45M	3.61M	2.87M	2.62M	2.15M	2.21M	2.29M	2.34M	2.77M	2.25M	378K	228K	122K	4K	465K	n/a
Total Assets	38.34M	48.89M	65.44M	82.32M	73.7M	100.45M	140.1M	180.1M	205.85M	244.82M	248.24M	211.04M	239.44M	261.33M	281.11M	200.39M	219.94M	238.75M	70.46M	85.81M	36.39M	43.7M	34.28M	40.33M	43.55M	47.87M	51.21M	56.32M	1.35M	n/a
Account Payables	15.99M	14.89M	13.26M	17.22M	13.65M	10.67M	11.2M	7.74M	10.23M	5.87M	6.02M	5.07M	4.68M	3.44M	2.5M	5.31M	3.98M	8.56M	10.43M	6.73M	4.95M	4.24M	3.98M	2.13M	1.6M	1.21M	889K	3.94M	444K	n/a
Deferred Revenue	n/a	n/a	n/a	85K	116K	-339K	23.09M	n/a	n/a	n/a	n/a	n/a	-293K	199K	-281K	-275K	7.39M	-676K	-934K	n/a	n/a	-420K	-501K	-783K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	353K	n/a	339K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	371K	n/a
Other Current Liabilities	35K	10.19M	2.44M	12.56M	12.99M	24.27M	4.16M	2.81M	6.46M	4.83M	10.07M	8.41M	7.43M	154K	7.22M	4.76M	2.07M	5.8M	4.54M	1.93M	1.88M	522K	3.21M	4.23M	n/a	n/a	n/a	13K	n/a	n/a
Total Current Liabilities	22.23M	25.56M	27.29M	31.48M	27.27M	39.41M	34.74M	28.76M	32.9M	23.38M	20M	16M	16.67M	14.6M	12.44M	12.32M	11.84M	16.34M	16.16M	12.27M	8.47M	8.21M	8.01M	6.81M	4.66M	2.04M	1.39M	4.21M	2.34M	n/a
Long-Term Debt	102.51M	104.44M	103.01M	101.63M	100.6M	99.09M	97.46M	95.77M	93.84M	91.69M	62.02M	1.03M	1.1M	1.18M	1.25M	1.33M	1.4M	1.47M	907K	n/a	n/a	1.07M	1.11M	1.15M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.63M	4.37M	9.19M	21.22M	1.91M	2.03M	1.41M	1.87M	1.56M	1.89M	1M	-1.03M	-1.1M	-1.18M	-1.25M	-1.33M	-1.4M	-1.47M	-907K	n/a	n/a	-1.07M	-1.11M	-1.15M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	109.21M	108.97M	112.45M	123.2M	102.94M	101.65M	99.49M	98.34M	96.18M	94.45M	63.98M	1.03M	1.1M	1.18M	1.25M	1.33M	1.4M	1.47M	907K	961K	1.03M	1.07M	1.11M	1.15M	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	131.44M	134.53M	139.74M	154.69M	130.21M	141.06M	134.23M	127.1M	129.08M	117.83M	83.97M	17.02M	17.77M	15.78M	13.7M	13.65M	13.24M	17.81M	17.07M	13.23M	9.5M	9.28M	9.12M	7.96M	4.66M	2.04M	1.39M	4.21M	2.34M	n/a
Total Debt	102.95M	104.97M	103.26M	102.34M	101.38M	99.62M	97.8M	96.09M	94.16M	92.88M	62.33M	1.33M	1.4M	1.47M	1.25M	1.33M	1.64M	1.47M	907K	961K	1.03M	1.07M	1.11M	1.15M	n/a	n/a	n/a	n/a	371K	n/a
Common Stock	49K	42K	40K	34K	30K	29K	29K	29K	28K	28K	28K	28K	28K	28K	28K	25K	24K	24K	20K	20K	18K	18K	16K	16K	16K	16K	16K	16K	10K	n/a
Retained Earnings	-650.2M	-639.34M	-625.69M	-617.39M	-590.6M	-568.34M	-517.86M	-464.34M	-411.55M	-356.74M	-314.93M	-277.26M	-245.79M	-219.66M	-192.85M	-165.23M	-138.86M	-117.77M	-93.02M	-71.6M	-56.69M	-48.41M	-39.4M	-30.92M	-23.72M	-16.64M	-11.76M	-8.73M	-4.45M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	0.00	0.00	0.00	n/a	n/a	0.00	-0.00	n/a	n/a	-317K	-269K	-221K	-174K	-127K	-78K	-40K	-18K	-10K	-3K	-1K	-1K	-324K
Shareholders Equity	-93.1M	-85.63M	-74.3M	-72.36M	-56.51M	-40.61M	5.86M	53.01M	76.78M	126.99M	164.26M	194.02M	221.67M	245.56M	267.41M	186.74M	206.7M	220.94M	53.39M	72.59M	26.89M	34.42M	25.16M	32.37M	38.89M	45.82M	49.82M	52.11M	-982K	-324K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a